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Trichuris muris is a laboratory model for the human whipworm Trichuris trichiura which infects
approximately 1 billion people in tropical and sub-tropical countries. The development of a vaccine
would control trichuriasis by promoting the acquisition of immunity during childhood, thereby reducing
faecal egg output by the community into their environment. Resistance to T. muris, deﬁned as expulsion
of the parasite prior to patency, requires the development of a T helper 2 (Th2) response during a primary
infection. To our knowledge this is the ﬁrst study to describe the protective immune response in the
peripheral lymph nodes (PLN), mesenteric lymph nodes (MLN) and colonic mucosa following s.c. vacci-
nation against T. muris. Susceptible AKR mice were either vaccinated with T. muris excretory–secretory
product (ES) in incomplete Freund’s adjuvant (IFA) (ES/IFA) or injected with PBS in IFA (PBS/IFA) and
for protection experiments were infected with embryonated infective T. muris eggs 10 days later. The
ES/IFA vaccine induced the proliferation of PLN cells and their production of Th2 cytokines and the
Th1-associated cytokine IFN-c. Following a challenge infection, the ES/IFA vaccination offered susceptible
mice complete protection. While MLN-derived IFN-c was produced by infected mice following either ES/
IFA vaccination or PBS/IFA, the protection of susceptible mice by ES/IFA was characterised by the produc-
tion of MLN-derived Th2 cytokines. Goblet cell hyperplasia and the inﬂux and alternative activation of
macrophages were observed locally in the gut post-challenge infection. The rate of epithelial turnover
did not appear to be increased by vaccination, suggesting that there are differences in the mechanisms
of expulsion between ‘natural resistance’ and ‘vaccinated resistance’. High levels of serum IgG1 and
cell-bound IgG1 in the colon of mice protected by the ES/IFA vaccine suggest that antibody may be
involved in vaccination-induced worm expulsion.
 2009 Australian Society for Parasitology Inc. Published by Elsevier Ltd.
Open access under CC BY license. 1. Introduction strain of mouse (Else et al., 1990). Some strains of mouse, suchTrichuris trichiura, the human whipworm, infects approximately
1 billion people in tropical and sub-tropical countries (Chan, 1997).
Anthelminthic drugs effectively clear gut-dwelling nematode par-
asites but are not a practical solution to trichuriasis since infection
is soon re-established in the human population from their environ-
ment. Rather, long-term immunological intervention strategies are
required to combat the disease. Trichuris muris infection of mice
may serve as a useful model in which to investigate the design of
a human vaccine since strong type 2 immune responses are asso-
ciated with host resistance to both T. trichiura (Jackson et al.,
2004) and T. muris (Else and Grencis, 1991). The range of protective
immunity mounted against T. muris in the mouse model of infec-
tion varies depending on the background genetics of the inbredInc. Published by Elsevier Ltd.
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).
Opas BALB/c, are resistant to T. muris and quickly expel the parasite,
whereas others such as AKR are susceptible, allowing the develop-
ment of a chronic infection of the cecum and proximal colon char-
acterised by the presence of fecund adult parasites.
Following a primary T. muris infection, it is now understood that
resistance requires the development of a type 2 response typiﬁed
by the release of mesenteric lymph node (MLN)-derived Th2 cyto-
kines leading to high levels of IgG1 in the serum. Susceptibility
occurs following the development of an inappropriate Th1 re-
sponse, which involves the release of IL-12 and IFN-c by MLN cells,
leading to elevated serum IgG2a levels (Else et al., 1993). While the
exact expulsion mechanism during primary infection is yet to be
elucidated, epithelial turnover, (Cliffe et al., 2005) goblet cells
(Artis et al., 2004) and macrophages (Deschoolmeester et al.,
2003; Little et al., 2005) have all been implicated. In isolation, nei-
ther mast cells, eosinophils, antibodies nor antibody-dependent
cellular cytotoxicity (ADCC) are essential for the resolution of pri-
mary infections (Else and Grencis, 1996; Betts and Else, 1999; Betts
et al., 2000). In contrast, little is known about the expulsion mech-
anisms in a secondary (challenge) infection.en access under CC BY license. 
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kins and Wakelin, 1977, 1983), poorly resistant C57BL/10 and sus-
ceptible B10.BR (Else and Wakelin, 1990; Robinson et al., 1995)
strains of mouse were successfully protected by a s.c. vaccination
consisting of T. muris adult excretory–secretory product (ES) in
either FCA or incomplete Freund’s adjuvant (IFA). However, neither
the immune response to vaccination nor the mechanisms underly-
ing worm expulsion, following a challenge infection, were studied
in detail. This study investigates the immune response to s.c. vacci-
nation with adult T. muris ES in IFA in the highly susceptible AKR
strain of mouse. Furthermore, this study examines the potential
effector mechanisms involved in the clearance of a challenge
infection.2. Materials and methods
2.1. Animals
Speciﬁc-pathogen-free male AKR and BALB/c mice (Harlan, Bic-
ester, UK) were maintained in micro-isolator cages in the animal
facility at the University of Manchester. Mice were vaccinated
and infected at 6–8 weeks old. They were fed autoclaved food
and water and all manual procedures were carried out under ster-
ile-ﬁltered laminar air ﬂow conditions.
All procedures carried out on animals were performed under a
Home Ofﬁce project license and complied at all times with UK laws
and regulations. All animal work was performed under the regula-
tions of the Home Ofﬁce Scientiﬁc Procedures Act (1986).
2.2. Parasite
The T. muris parasite was maintained and the mice were in-
fected with eggs by oral gavage (Wakelin, 1967). Worm burdens
were assessed (Else et al., 1990) and worm ES antigens were pre-
pared (Bancroft et al., 1998). Brieﬂy, live adult worms were cul-
tured for 4 h at 37 C and the ES antigens were prepared for the
later in vitro re-stimulation of MLN cells. The culture medium
was replenished and the worms were incubated overnight at
37 C. This yielded ES antigens for the preparation of the vaccine
and for use in antibody ELISAs and Western blots.
2.3. Vaccination
Sterile-ﬁltered ES antigenswere emulsiﬁedwith an equal volume
of IFA (Sigma–Aldrich,Dorset, UK) to achieve a vaccinedose of100 lg
ES in 100 ll (1 mg/ml ES/IFA). Accordingly, control mice were in-
jected with 100 ll PBS/IFA. In the standard protocol, vaccinations or
control injections were administered s.c. in one abdominal site and
an infection was given 10 days later. Alternatively, mice were vacci-
nated with a total vaccine dose of 100 lg ES in 100 ll ES/IFA or in-
jected with PBS/IFA split between several s.c. sites at either 12, 9, 6
or3 dayspriortoautopsybutwerenotsubsequently infected.The lat-
ter approach was taken in order to investigate the proliferation of
peripheral lymph node (PLN) cells and their release of cytokines.
2.4. In vitro re-stimulation of MLN and PLN cells
The MLN and the axillary, brachial and inguinal PLN were re-
moved at autopsy and dissociated in RPMI-1640 media supple-
mented with 10% FCS, 2 mM L-glutamine, 100 U/ml of penicillin,
100 lg/ml streptomycin (all Invitrogen Ltd., Paisley, UK). MLN or
PLN cells (5  106 per well in 48-well plates) were re-stimulated
in vitro with T. muris ES antigens (50 lg/ml) at 37 C. The superna-
tants were collected after 48 h and stored at 20 C until cytokine
analysis was performed. Alternatively, the lymph node cells(1  106 per well in 96-well plates) were re-stimulated in vitro
with T. muris ES antigens (50 lg/ml) at 37 C for 72 h prior to the
measurement of proliferation by the MTT [3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyl tetrazolium bromide] assay.
2.5. Cytokine analysis
Sandwich ELISAs were used to determine the concentrations of
IL-5, IL-9, IL-12, IL-13 and IFN-c in the supernatants recovered
from in vitro-cultured MLN and PLN cells, as described previously
(Taylor et al., 2000). The IL-13 ELISA was performed using the
Quantikine M Mouse IL-13 Colorimetric Sandwich ELISA kit (R&D
Systems, Abingdon, UK).
2.6. MTT eluted stain assay
Cell proliferation was measured using the MTT eluted stain as-
say (Mosmann, 1983). Brieﬂy, 50 lg/ml MTT (Sigma–Aldrich) was
added to each well and the plate cultured at 37 C for 60 min. Fol-
lowing this, 100 ll of acidiﬁed isopropanol was added to each well
and the wells were mixed by pipetting. The plate was read at
560 nm on a MRX II microplate reader (Dynex Technologies Ltd.,
Worthing, West Sussex, UK) with the reference ﬁlter set at 630 nm.
2.7. Histology
At autopsy, colonic tissue samples were taken from the site
immediately distal to the cecum. Samples were ﬁxed at room tem-
perature for 4 h in Carnoy’s ﬁxative, or overnight in 10% neutral-
buffered formalin, prior to processing and embedding in parafﬁn
wax. Serial sections, 5 lm thick, were de-waxed in citroclear and
rehydrated prior to staining with either H&E, toluidine blue or
Schiff’s reagent which stain eosinophils, mast cells or goblet cells,
respectively. The number of each cell type in the colonic epithe-
lium was counted and expressed per 20 crypt units.
2.8. Crypt length
Photographs of colonic sections for crypt length measurement
were taken at 100 magniﬁcation on a Nikon Eclipse E400 micro-
scope using SPOT Advanced version 3.5.5 software. Twenty crypt
lengths were measured per mouse using Image-Pro Plus version
4.5.1.22 image-analysis software and the average crypt length
per mouse was calculated.
2.9. Immunohistochemistry
Colorimetric immunohistochemistry, employing standard imm-
unoperoxidase techniques (Little et al., 2005), was carried out using
one of the following biotinylated rat, anti-mouse monoclonal anti-
bodies (mAbs): anti-IgG1 (5 lg/ml; BD Biosciences, Oxford, UK),
anti-IgA (5 lg/ml; BD Biosciences), anti-CD4 (7.5 lg/ml; BD Biosci-
ences), anti-B220 (10 lg/ml; BD Biosciences), anti-F4/80 (7.5 lg/
ml; Serotec, Oxford, UK). Alternatively, staining was achieved using
either puriﬁed rabbit anti-mouse iNOS (5 lg/ml; BD Biosciences) or
rat anti-mouseFIZZ1 (5 lg/ml;R&DSystems,Abingdon,UK) followed
by a biotinylated secondary antibody (Ab) (Chemicon International,
California, USA). The sections were incubated in parallel with the
appropriate biotinylatedorpuriﬁed isotype control Abs, as applicable
(BD Biosciences). The blue nuclear dye Hematoxylin QS (Vector Lab-
oratories Ltd., Peterborough, UK), was used as a counter-stain. The
number of positively stained cells in 20 crypts was counted at high
magniﬁcation using a Nikon Eclipse E400microscope. Digital photo-
graphs were taken using SPOT Advanced version 3.5.5 software.
In brief, for dual immunoﬂuorescence staining, the sections
were incubated for 1 h with either biotinylated anti-IgG1 or anti-
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(30 lg/ml; Vector Laboratories Ltd.) for 30 min. Avidin and biotin
binding sites were then saturated using an avidin/biotin blocking
kit (Vector Laboratories Ltd.). The sections were then incubated
with either biotinylated anti-B220 or anti-F4/80 (BD Biosciences)
for 1 h, followed by avidin-conjugated FITC for 30 min (30 lg/ml;
Vector Laboratories Ltd.). The sections were mounted in Vector-
shield mounting medium containing the blue nuclear counter-
stain DAPI (Vector Laboratories Ltd.). Digital images were captured
using an Olympus Bx-1 ﬂuorescence microscope ﬁtted with a Cool-
snap camera and Metavue software.
2.10. Parasite-speciﬁc antibody detection in the serum
Blood was taken immediately postmortem by cardiac puncture
and left at room temperature to clot. The serum was collected from
each sample, then aliquoted and stored at 20 C prior to the anal-
ysis of parasite-speciﬁc IgG1 and IgG2a levels by ELISA as previ-
ously described (Else et al., 1993).Fig. 1. Worm burden and mesenteric lymph node cell (MLNC) cytokine proﬁle at day 21
p.i. with Trichuris muris in naive, PBS/incomplete Freund’s adjuvant (IFA)-injected and
injected and ES/IFA-vaccinated groups were infected with approximately 150 infective
presence of (B) IL-5, (C) IL-9, (D) IL-13, (E) IL-12p40 and (F) IFN-c. Results are shown as m
above naive levels (P < 0.05). A signiﬁcant difference between infected groups is indicated
one of two experiments.2.11. Statistical analyses
The data presented here are from one of two experiments. All
groups contained ﬁve animals at each time-point unless otherwise
stated. Signiﬁcant differences between multiple groups (P < 0.05)
were determined by the Kruskall–Wallis non-parametric ANOVA
with the Mann–Whitney U test modiﬁed by the Bonferroni correc-
tion as post-test. Signiﬁcant differences between two groups were
determined by the Mann–Whitney U test. Statistical analyses were
carried out using GraphPad Prism software, version 3.02.3. Results
3.1. ES/IFA vaccine protects susceptible AKR mice from T. muris
The ES/IFA vaccine induced a mean protection rate of 97% by
day 21 p.i. (Fig. 1A). This consisted of 100% expulsion in two mice
and 99%, 95% and 91% expulsion in the other three mice. By day 35p.i. (A) Worm burdens and (B–F) cytokine analyses of MLNC supernatants on day 21
excretory–secretory product (ES)/IFA-vaccinated AKR mice. Mice in the PBS/IFA-
embryonated T. muris eggs on day 0. MLNC supernatants were analysed for the
eans ± SD (n = 5 per group).  above error bar indicates cytokine levels signiﬁcantly
by with a line (P < 0.05) or with a line (P < 0.01). The results presented are from
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mice (data not shown).3.2. Protection is associated with the release of Th2 cytokines by MLN
cells following vaccination and a subsequent challenge infection
The MLN cells from ES/IFA-vaccinated mice at 21 days p.i. re-
leased high levels of the Th2 cytokines IL-5, IL-9 and IL-13 upon
their re-stimulation in vitro with worm ES antigens (Fig. 1B–D).
In contrast, the MLN cells from both PBS/IFA-injected control mice
at 21 days p.i. and untreated naive mice produced these cytokines
only at low levels (Fig. 1B–D). Post-infection, MLN cells from PBS/
IFA-injected control mice, but not ES/IFA-vaccinated mice, pro-
duced higher levels of the Th1 cytokine IL-12p40 compared with
MLN cells from untreated naive mice (Fig. 1E). However, MLN cellsFig. 2. Cell proliferation and cytokine production proﬁles of peripheral lymph node ce
product (ES)/incomplete Freund’s adjuvant (IFA) vaccination or PBS/IFA injection. (A)
tetrazolium bromide] eluted stain assay and (B–E) cytokine analyses of in vitro ES-re-stim
symbols) and ES/IFA-vaccinated (black symbols) AKR mice. Mice were vaccinated 12, 9,
n = 6 per group except in the MTT assay where on day 6 n = 2 for PLNC from PBS/IFA-in
*P < 0.05, **P < 0.01, ***P < 0.001. The results presented are from one of two experimentfrom both the ES/IFA-vaccinated and the PBS/IFA-injected control
mice released higher levels of the Th1 cytokine IFN-c p.i. compared
with those from untreated naive mice (Fig. 1F).3.3. Vaccination (without a subsequent challenge infection) induces
the proliferation of, and release of Th2 cytokines by, PLN cells
From 6 days post-vaccination, ES antigens induced the prolifer-
ation in vitro of PLN cells from ES/IFA-vaccinated unchallenged
mice. This was not observed, at any time-point, in PLN cells from
PBS/IFA-injected unchallenged control mice nor in MLN cells from
ES/IFA-vaccinated unchallenged mice (Fig. 2A).
Accordingly, PLN cells (from the ES/IFA-vaccinated group of
mice only), but not MLN cells, produced the Th2 cytokines IL-5
and IL-13 in response to stimulation in vitro by ES antigenslls (PLNC) and mesenteric lymph node cells (MLNC) following excretory–secretory
Cell proliferation as measured by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
ulated MLNC (triangles) and PLNC (squares) harvested from PBS/IFA-injected (open
6 and 3 days prior to autopsy. Results are shown as means ± SD. For all time-points
jected AKR mice. Signiﬁcant differences between the three groups are indicated by
s.
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ment with PBS/IFA, resulted in the elevation of IL-12p40 release
(Fig. 2D) by PLN- or MLN-derived cultured cells. However, another
Th1 cytokine, IFN-c, was produced by PLN (but not MLN) cells ta-
ken from ES/IFA-vaccinated mice but not from PBS/IFA-injected
control mice (Fig. 2E).
3.4. Crypt hyperplasia is observed in ES/IFA-vaccinated and PBS/IFA-
injected mice following a challenge infection
The length of colonic crypts was measured in order to serve as
an index of crypt hyperplasia. Prior to a challenge infection, there
was no difference in the average length of colonic crypts between
naive mice, ES/IFA-vaccinated mice and PBS/IFA-injected mice
(10 days post-treatment, not shown). However, following a chal-
lenge infection, both the ES/IFA-vaccinated mice and the PBS/IFA-
injected mice exhibited crypt hyperplasia (Fig. 3A).
3.5. A description of the cellular inﬁltrate following vaccination and
subsequent challenge infection
The number of colonic CD4+ T cells was higher in both PBS/IFA-
injected challenged and ES/IFA-vaccinated challenged mice than in
untreated uninfected naive mice (Fig. 3B). There were signiﬁcantly
more CD4+ cells in the chronically infected PBS/IFA-injected con-
trol group compared with the vaccinated protected group
(Fig. 3B). Compared with untreated, uninfected naive mice, there
were more colonic B220+ B cells (Fig. 3C), eosinophils (Fig. 3D)
and mast cells (Fig. 3E) in both PBS/IFA-injected challenged and
ES/IFA-vaccinated challenged mice. The recruitment of B220+ B
cells (Fig. 3C), eosinophils (Fig. 3D) and mast cells (Fig. 3E) to the
colon was higher in protected ES/IFA-vaccinated mice than in
chronically infected PBS/IFA-injected control mice. Compared with
untreated uninfected naive mice, there were more colonic goblet
cells in ES/IFA-vaccinated challenged mice but not in PBS/IFA-in-
jected challenged control mice (Fig. 3F). Thus, the colons of pro-
tected ES/IFA-vaccinated mice contained more goblet cells than
those of chronically infected PBS/IFA-injected control mice. There
were more colonic F4/80+ macrophages in both the ES/IFA-vacci-
nated and PBS/IFA-injected challenged groups compared with the
untreated naive group (Fig. 3G). The colons of protected ES/IFA-
vaccinated mice contained more F4/80+ macrophages than the co-
lons of chronically infected PBS/IFA-injected mice (Fig. 3G). Fur-
thermore, F4/80+ macrophages were found mainly at the base of
the crypts in PBS/IFA-injected mice but were found both at the
base and along the length of the crypts in ES/IFA-vaccinated mice
(Fig 3G). Each of the aforementioned types of cell was also quanti-
ﬁed before the challenge infection (10 days post-treatment). In this
case, neither the ES/IFA vaccine nor the PBS/IFA injection affected
the number of these cells in the colon compared with untreated
naive controls (data not shown).
3.6. ES/IFA vaccination induces alternatively activated macrophages
The colonic macrophages were further characterised 21 days
p.i. for iNOS and Arg1 expression, markers of classical and alterna-
tive activation, respectively (Lyons et al., 1992; Loke et al., 2002).
These cells were quantiﬁed not only in our AKR mouse model of
vaccination but also in naturally resistant BALB/c mice. Arg1+ and
iNOS+ cells in gut tissue are quantiﬁed in Fig. 4B and D with images
from pertinent groups shown as examples of staining in Fig. 4A and
C. There were few colonic Arg1+ cells in untreated naive mice of
either strain. This was also observed post-infection in PBS/IFA-in-
jected control AKR mice (Fig. 4A and B). However, there were sig-
niﬁcantly more colonic Arg1+ cells in the ES/IFA-vaccinated AKR
mice post-challenge with T. muris infection. This mirrored the in-crease in Arg1+ cells in resistant BALB/c mice as part of their natu-
ral immune response to the parasite (Fig. 4A and B). There were
few colonic iNOS+ cells in untreated naive mice of either strain
(Fig. 4C and D). Neither the natural immune response in resistant
BALB/c mice, nor the successful immune response in vaccinated
AKR mice to a challenge infection involved an increase in the num-
ber of colonic iNOS+ cells (Fig. 4C and D). In contrast, such an in-
crease was observed both during the unsuccessful natural
immune response of AKR mice to T. muris and in PBS/IFA-injected
control AKR mice upon a challenge infection (Fig. 4C and D).
3.7. Serum antibody responses following ES/IFA vaccination
Thirty-ﬁve days after a primary infection, parasite-speciﬁc
IgG1 production is associated with a protective Th2 response
to T. muris in resistant strains of mouse. Conversely, parasite-
speciﬁc IgG2a production is a feature of the inappropriate Th1
response in susceptible strains of mouse (Else et al., 1993).
Thirty-ﬁve days after the challenge infection, ES/IFA-vaccinated
mice had higher levels of parasite-speciﬁc IgG1 in their serum
than both untreated naive mice and PBS/IFA-injected control
mice (Fig. 5A). At the same time after challenge infection, both
the ES/IFA-vaccinated group and the PBS/IFA-injected group pro-
duced higher levels of IgG2a than the untreated naive group.
Vaccination with ES/IFA resulted in higher levels of IgG2a at
35 days p.i. than injection with PBS/IFA (Fig. 5B).
In order to investigate whether ES/IFA vaccination induced
detectable levels of parasite-speciﬁc antibodies in the serum dur-
ing the period of worm expulsion, IgG1 and IgG2a were measured
in the serum of mice 10 days post-vaccination but prior to infec-
tion (day 0) and again at 21 days post-challenge infection. At day
0, ES/IFA vaccination raised serum IgG1 levels signiﬁcantly above
those in untreated naive mice and in PBS/IFA-injected controls
(Fig. 5C). Although there appeared to be even higher levels of
IgG1 in ES/IFA-vaccinated mice 21 days after the challenge infec-
tion, this was not statistically signiﬁcant (Fig. 5C). At these time-
points, only negligible levels of IgG2a were detected in the serum
in any group of mice (Fig. 5D).
3.8. Mucosal antibody responses following ES/IFA vaccination
In the ES/IFA-vaccinated mice, 21 days post-challenge infection,
strong staining of IgG1 was seen throughout the extracellular ma-
trix of the colonic lamina propria (Fig. 6A). IgG1+ cells were present
both at the base and along the length of the crypts (Fig. 6A). Neg-
ligible IgG1 staining was found in the colonic mucosa of untreated
naive mice (Fig. 6A). Following PBS/IFA injection and subsequent
challenge infection, only weak extracellular staining of IgG1 was
observed in the lamina propria and there were few IgG1+ cells
present at the base of the crypts (Fig. 6A). Following a challenge
infection, there were signiﬁcantly more IgG1+ cells in the colonic
lamina propria of ES/IFA-vaccinated mice than PBS/IFA-injected
control mice (Fig. 6A). No staining of any sort was seen with the
isotype control antibody (data not shown).
In ES/IFA-vaccinated mice, IgA staining was seen at the luminal
surface of epithelial cells – especially goblet cells – and on lamina
propria leukocytes (LPL) (Fig. 6B). There were signiﬁcantly more
IgA+ leukocytes in ES/IFA-vaccinated mice, post-challenge infec-
tion, than in untreated naive mice. No staining was seen with the
isotype control antibody (data not shown).
Immunoﬂuorescence staining conﬁrmed that the location of
IgG1 was both cellular and extracellular (Fig. 6C). The types of cell
producing the IgG1 or IgA were revealed by dual immunoﬂuores-
cence staining. An isolated lymphoid follicle (ILF) is shown in
Fig. 6D. A few IgG1+ B220+ cells were seen near the periphery of
the ILF but the majority of B220+ ILF cells, in the cortex, do not
Fig. 3. Colonic crypt length and cell inﬁltration. Representative photographs and numbers of (A) colonic crypt lengths and (B) CD4+ (C) B220+ (D) eosinophil (E) mast (F)
goblet and (G) F4/80+ cells in the colonic mucosa of naive and infected PBS/incomplete Freund’s adjuvant (IFA)-injected and excretory–secretory product (ES)/IFA-vaccinated
AKR mice on day 21 p.i. CD4+, B220+ and F4/80+ cells appear brown in immunohistochemical (IHC) stained sections. Eosinophils have a blue nucleus and pink cytoplasm in
H&E stained sections and examples are marked by an arrow. Mast cells appear blue and granular in toluidine blue while goblet cells appear pink-purple in Schiff’s stained
sections. All photographs shown were taken at 400 original magniﬁcation. Graphed results are shown as mean cell numbers per 20 crypt units (cu) ± SD (n = 5 per group). 
above the error bar indicates that cell numbers are signiﬁcantly above naive levels (P < 0.05). A signiﬁcant difference between infected groups is indicated by  with a line
(P < 0.05). The results presented are from one of two experiments.
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Fig. 4. Excretory–secretory product (ES)/incomplete Freund’s adjuvant (IFA) vaccination induces alternatively activated macrophages. (A and C) Representative photographs
and (B and D) numbers of (A and B) Arg1+ and (C and D) iNOS+ cells in the colonic mucosa of: naive BALB/c (BN); naive AKR (AN); infected BALB/c (BI); infected AKR (AI);
PBSIFA-injected and infected AKR (AP); ES/IFA-vaccinated and infected AKR (AV) mice on day 21 p.i. Arg1+ and iNOS+ cells appear brown in immunohistochemical (IHC)
stained sections. All photographs were taken at 400 original magniﬁcation. Graphed results are shown as mean cell numbers per 20 crypt units (cu) ± SD (n = 5 per group). (B
and D)  above the error bar indicates that cell numbers are signiﬁcantly above naive levels (P < 0.05). (D) with a line indicates a signiﬁcant difference (P < 0.05) between the
infected PBS/IFA-injected and ES/IFA-vaccinated groups and between the infected non-vaccinated AKR and ES/IFA-vaccinated groups. The results presented are from one of
two experiments.
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in the gut mucosa (Fig. 6E). Most F4/80+ cells in the colonic mucosa
of ES/IFA-vaccinated mice were IgG1+ (Fig. 6F). Immunoﬂuores-
cence staining revealed that IgA was expressed by both LPL and
epithelial cells (Fig. 6G). Although no B220+ IgA+ cells were found
in the ILF (Fig. 6H) they were encountered in the lamina propria
(Fig. 6I). Few IgA+ F4/80+ cells were seen in the gut mucosa; indeed
most F4/80+ cells were IgA (Fig. 6J).4. Discussion
In this study, the vaccine conferred rapid and complete protec-
tion against T. muris to the highly susceptible AKR strain of mouse.
With kinetics similar to that observed during natural worm expul-
sion in the highly resistant BALB/c strain of mouse (Cliffe et al.,
2005), the vaccine achieved total expulsion before the parasites
reached patency, thereby preventing environmental contamina-
tion with eggs. Ultimately, this would be the goal of a human vac-
cine against T. trichiura. While previous studies vaccinated
susceptible strains using ES in FCA, protection was slow to develop
and rather than sterile immunity, only a reduction in the worm
burden was achieved (Else and Wakelin, 1990). Indeed, many
anti-nematode vaccine trials in farm animals do not result in ster-
ile immunity (Newton and Munn, 1999). Therefore, our model sys-
tem may be useful and relevant for investigating both the
development of immunity in response to vaccination and the
mechanisms of parasite expulsion following challenge infection.
It is not understood how a vaccine administered s.c. may lead to
the successful development of immunity against a nematode resid-
ing in a distant and distinct site such as the large intestine. Adding to
the confusion, tissue-homing effector T cells are thought to be pro-
grammed to return to the site in which the antigen was initially
encountered and presented (Fabbri et al., 1999). Several potentialmechanisms of parenterally induced mucosal immunity have been
proposed which, in one way or another, all point to the MLN as the
initial site of antigen presentation to T cells. These theories include:
the diffusion of antigens through the circulation to the mucosal-
associated lymphoid tissue (MALT) (Bouvet et al., 2002), the migra-
tion of dendritic cells from the skin to theMALT (Kripke et al., 1990;
Enioutina et al., 2000; Belyakov et al., 2004) or themigration of anti-
gen-presenting B cells from the PLN to theMALT (Cofﬁn et al., 1999).
The initial site of antigen presentation following s.c. vaccination
against T. muris has not previously been identiﬁed. This study re-
veals that, soon after s.c. vaccination, it is the PLN cells, but not the
MLN cells, which proliferate and release cytokines. Therefore, in
our model, the initial antigen presentation seems to occur in the
PLN – the local draining lymph nodes of the skin. Further evidence
from our laboratory in support of this comes from a different model
system in which either PLN cells or MLN cells are adoptively trans-
ferred from ES/IFA-vaccinated BALB/c mice into susceptible severe
combined immunodeﬁcient (SCID) mice. When the recipient mice
are challengedby infectionwithT.muris, PLNcells, butnotMLNcells,
confer resistance (Dixon and Else, unpublished data).
Various Th2 cytokines, and the Th1 cytokine IFN-c, are released
by PLN cells following vaccination and then by MLN cells following
the challenge infection. Notably however, another Th1 cytokine, IL-
12, is not produced in response to vaccination or vaccination and
challenge infection but is produced by the MLN cells of chronically
infected PBS/IFA-injected AKR mice. Therefore, the vaccine fully in-
duces the typical Th2 response seen in primary infections of the
naturally resistant BALB/c mouse but only partially induces the
classical Th1 response seen in primary infections of the naturally
susceptible AKR mouse. IL-12 is important for initial polarisation
towards a Th1 response (O’Garra and Murphy, 2009) and absence
of this cytokine may be critical to the development of a protective
immune response to T. muris. While the vaccine does elicit a mixed
Th1/Th2 response with both the Th2-associated IgG1 and the
Fig. 5. Serum antibody responses following ES/IFA vaccination. Sera from naive and Trichuris muris-infected PBS/incomplete Freund’s adjuvant (IFA)-injected and excretory–
secretory product (ES)/IFA-vaccinated AKR mice were assayed by ELISA for parasite-speciﬁc (A and C) IgG1 and (B and D) IgG2a at (A and B) day 35 p.i. and (C) IgG1 and (D)
IgG2a levels are compared between day 0 and day 21 p.i. Results are shown as means ± SD (n = 5 per group). Naive levels are depicted by a cross, PBS/IFA-injected levels by a
circle and ES/IFA-vaccinated levels by a square. Non-infected groups are indicated by open symbols while infected groups are indicated by closed symbols. Statistical analyses
were carried out from data from the (A) 1:5,120 dilution, from the (B) 1:1,280 dilution and from the (C and D) 1:80 dilution. Signiﬁcant differences between groups are
represented by a  and a table of signiﬁcant differences between groups is presented in (E). The results presented are from one of two experiments.
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only the Th2-associated IgG1 is produced during the critical periodfor worm expulsion (day 0–21 post-challenge). Thus, the present
study suggests that similar to primary infection a Th2 response –
Fig. 6. Mucosal antibody responses following ES/IFA vaccination. (A and B) Colorimetric immunohistochemical (IHC) staining and numbers of (A) IgG1+ and (B) IgA+ (IgA+
epithelial and goblet cells not counted) leukocytes in the colonic mucosa of naive and Trichuris muris-infected PBS/incomplete Freund’s adjuvant (IFA)-injected and excretory–
secretory product (ES)/IFA-vaccinated mice at day 21 p.i. IgG1+ and IgA+ cells appear brown in colorimetric IHC stained sections. Graphed results are shown as mean cell
numbers per 20 crypt units (cu) ± SD (n = 5 per group).  above the error bar indicates that cell number is signiﬁcantly above naive levels (P < 0.05).  with a line indicates a
signiﬁcant difference in IgG1+ cell numbers (P < 0.05) between the infected groups. (C–J) Fluorescent IHC staining of colonic sections from infected ES/IFA-vaccinated mice
showing (C) IgG1+ (D) ILF B220+ and IgG1+ (E) B220+ and IgG1+, (F) F4/80+ and IgG1+, (G) IgGA+ (H) ILF B220+ and IgA+ (I) B220+ and IgA+, (J) F4/80+ and IgA+ cells. (G) White
arrow depicts goblet cell staining while yellow arrows depict leukocyte staining for IgA. The results presented are from one of two experiments.
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the expulsion of T. muris in a secondary infection.
In a primary infection, the migration of T helper cells to the
large intestine is critically required for the expulsion of T. muris
(Picarella et al., 1997; Betts et al., 2000) but colonic CD4+ cell accu-
mulation can be demonstrated in both resistant and susceptible
strains. To clarify, such migration of leukocytes in susceptible
AKR mice is the result of the inappropriate Th1 response mounted
by this strain to the parasite. Similarly, there is an accumulation of
CD4+ cells in the gut following a challenge infection in both ES/IFA-
vaccinated and PBS/IFA-injected control mice. Recently, several
locally acting T-cell-dependent effector mechanisms have been
elucidated which are ultimately responsible for the expulsion of
T. muris in a primary infection. The effector mechanisms underly-ing the expulsion of worms from vaccinated mice challenged by
a T. muris infection have not been previously investigated.
In resistant BALB/cmice, an increase in the rate of epithelial turn-
overhasbeen showntobeakeyeffectormechanismin theexpulsion
of worms (Cliffe et al., 2005). This IL-13-dependent event results in
the shortening of epithelial crypts. In contrast, during a chronic
infection in susceptible AKRmice, IFN-c-driven intestinal epithelial
cell hyperproliferation occurs (Artis et al., 1999; Cliffe et al., 2005).
This is responsible for crypt hyperplasia, leading to an increase in
the length of the epithelial crypts.Hence, resistant BALB/cmice have
shorter crypts than susceptible AKRmice during a primary infection
(Cliffe et al., 2005). In the present study, both ES/IFA-vaccinated and
PBS/IFA-injected challengedmicehad longer crypts thannaivemice,
suggesting that crypthyperplasiaoccursduring thevaccine-induced
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about by the high levels of IFN-c which accompany the response.
Hence, although an increase in the rate of epithelial cell turnover re-
sults in worm expulsion in naturally resistant BALB/c mice during a
primary infection (Cliffe et al., 2005), thismechanismwould not ap-
pear to be implicated in the expulsion of worms by vaccinatedmice
during a challenge infection.
Despite themarked eosinophilia andmastocytosis in the gut dur-
ing a primary infection, worm expulsion can proceed unhindered in
the absence of eosinophils andmast cells (Betts and Else, 1999; Koy-
ama and Ito, 2000; Dixon et al., 2006). Eosinophils are able to kill the
larvae of migratory nematodes such as Trichinella spiralis (Grove
et al., 1977;WassomandGleich, 1979;Gurish et al., 2002) andBrugia
malayi (Simons et al., 2005).Mast cells are required for the expulsion
of the small intestinal nematode T. spiralis (Grencis et al., 1993).
Therefore, in our vaccination and challengemodel, the greater inﬂux
of eosinophils andmast cells following ES/IFA vaccination than PBS/
IFA injection may merely indicate a general type 2 anti-nematodal
response in the former. However, eosinophils may contribute to
ADCC involving IgA or IgG1 (bu-Ghazaleh et al., 1989; Khalife et al.,
1989; Nutten et al., 1999) as eosinophils mediate ADCC against hel-
minths in vitro (Butterworth et al., 1975; Glauert and Butterworth,
1977; Venturiello et al., 1995). To address the role for eosinophils
in vaccination-inducedprotection, vaccination of aneosinophil-deﬁ-
cient mousemodel, such as theDdbl GATA-1mouse (Yu et al., 2002)
would be required. Althoughmast cells are not thought to be impor-
tant in themechanismsof resistance toaprimary infection (Betts and
Else, 1999; Koyama and Ito, 2000) their local elevation in vaccinated
infected mice may indicate a role in protection after vaccination.
Vaccination ofmice depleted ofmast cells using anti-stem cell factor
antibodies or transgenic mice deﬁcient in mucosal mast cell prote-
ase-1 (Knight et al., 2000) will allow the role of the mast cell and its
products in vaccine-induced protection to be critically assessed.
The role macrophages play in the mechanism of resistance to T.
muris is still unclear in both primary and challenge infections.
CCL2-deﬁcient mice exhibit reduced recruitment of macrophages
to the colonic mucosa and are also unable to expel T. muris during
a primary infection (Deschoolmeester et al., 2003). Alternatively
activated macrophages have been implicated in the expulsion of a
variety of parasites, including several nematodes (Anthony et al.,
2006). However, the accumulation of alternatively activatedmacro-
phages in both ‘naturally resistant’ BALB/c and ‘vaccinated resistant’
AKR mice at day 21 p.i., a time-point at which most of the worms
have already been expelled from the gut, may reﬂect the role of
the macrophage in the resolution of inﬂammation and in directing
the repair of damaged tissue (Shearer et al., 1997; Liu et al., 2004).
In the present study, colonic goblet cell hyperplasia, in response
to the challenge infection, occurs only in the vaccinated mice. Gob-
let cell hyperplasia, which is IL-13-dependent (McKenzie et al.,
1998), is also a prominent response to a primary infection in resis-
tant strains of mouse (Datta et al., 2005; Owyang et al., 2006). The
release of RELM-b by goblet cells during infection is thought to
inhibit the chemotaxis of T. muris into the epithelium, thereby
dislodging the parasite into the lumen (Artis et al., 2004). This
putative mechanism of expulsion may also play a role in the
vaccine-driven response to a challenge infection.
Following theprimary infection of resistant strains ofmousewith
T. muris there is an appreciable increase in the levels of parasite-spe-
ciﬁc IgG1 in the serum. However, this develops after the parasite has
already been expelled (Else et al., 1993). Therefore, rather than play-
inga role in theexpulsionofaprimary infection, IgG1 ismore likely to
be involved in thememory response of the adaptive immune system
to a subsequent infection. Signiﬁcantly, early studies showed that
while immunity could be transferred with either the serum or cells
of protected mice, the highest levels of protection were achieved by
the transfer of serum (Selby and Wakelin, 1973). Furthermore, theadoptive transfer of puriﬁed T. muris-speciﬁc IgG1 provides partial
protection to susceptible strains of mouse (Blackwell and Else,
2001) while lMT mice, which lack B cells, cannot be protected
against T. muris by s.c. vaccination (Blackwell and Else, unpublished
data). In the present study, parasite-speciﬁc IgG1 is present at high
levels in the serum following vaccination prior to infection and at
day 21 post-challenge infection towards the end of worm expulsion.
Therefore, IgG1-dependentmechanismsmaybe central to theexpul-
sion of T. muris in vaccinated mice. Since T. muris resides in the large
intestine, in order to be effective IgG1must be present in the colonic
mucosa. Indeed, we show IgG1 located in the extracellular matrix of
the lamina propria and signiﬁcantly increased numbers of IgG1+ B
cells andmacrophages in the colonic mucosa of vaccinatedmice fol-
lowing the challenge infection. Future studies will analyse local tis-
sue levels of IgG1 at early time-points post-infection in order to
correlate this with larval clearance. IgA is also present in the colonic
mucosa of vaccinated resistantAKRmiceand therefore itmayalsobe
involved in the expulsion mechanism. The adoptive transfer of T.
muris-speciﬁcmonoclonal IgAantibodieshaspreviouslybeenshown
to reduce the worm burden (Roach et al., 1991) and IgA has previ-
ously been shown in the colon followingmucosal vaccination, corre-
lating with resistance to T. muris (Robinson et al., 1995). IgA is
secreted into the lumen of the intestine and by binding tomolecules
on the nematode surface it could prevent nematode adhesion to the
colon or facilitate worm killing by ADCC (Nutten et al., 1999).
This paper describes a model system of s.c. vaccination against T.
muris in which sterile immunity is conferred to susceptible mice. To
our knowledge for the ﬁrst time, the initial immune response to such
a vaccine was investigated andwas shown to occur in the PLN rather
than theMLN.This is also theﬁrst studytodescribe the recruitmentof
leukocytes into the large intestine in vaccinated mice following a
challenge infection. Although the expulsion mechanisms operating
in eachmodel are yet to be fully elucidated, it seems thatwhile accel-
erated epithelial turnover is essential in the expulsion of a primary
infection, it is unlikely to play a role in themechanism of vaccine-in-
duced resistance. Potentially, antibody-dependent mechanisms play
a more prominent role in the vaccine-induced expulsion of worms.
Using this vaccination model, future work in our laboratory will
establish which elements of the immune response are required to
confer protection against T. muris. Through long-term studies it will
also be important to identify the longevity of protection offered by
vaccination and to establish vaccination regimes which maximise
the duration of action. This will further aid the rational design of an
anti-Trichuris vaccine. Since all currently licensed vaccines work by
eliciting an antibody response directed at the pathogen, the involve-
ment of antibodies in vaccine-induced protection against T. muris
would be encouraging.
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